Industries' prospects under Obama

Industries' prospects under Obama

Here are industries that are potentially out of favor or are relatively well positioned under an Obama administration:

OUT OF FAVOR

Tobacco: Expansion of the State Children's Health Insurance Program would be funded by a federal excise tax increase on tobacco products.

Big oil companies: Obama has proposed windfall profits taxes when a barrel of oil is more than $80.

Coal mining: A system of capping and trading carbon emissions would favor natural gas and nuclear power.

Alternative investments: Obama supports taxing carried interest as regular income.

Brokers and asset managers: Would be affected by a higher tax on capital gains.

Credit card companies: Obama has proposed to ban universal defaults and interest on fees.

Multi-line insurance companies: Obama has proposed preventing insurers from overcharging for malpractice insurance.

Tax preparation companies: Obama has proposed simplifying tax filings for middle-class Americans.

Biotech: "Biogenerics," or generic biotech drugs, would be at a disadvantage.

Managed care: Government intervention poses risks.

Pharmaceuticals: A greater government role in Medicare drug prices is expected.

Upscale retailers: Higher taxes on upper-income groups would be a negative for luxury goods.

Coal-burning utilities: Potentially at risk from a carbon cap-and-trade system.

High-payout utilities: A higher tax on dividends would be a negative for high-payout stocks.

RELATIVELY WELL POSITIONED

Ethanol producers: Obama supports subsidies and tariffs for ethanol.

Nuclear-powered utilities: Well positioned under a carbon cap-and-trade system.

Solar and wind power companies: Obama favors renewable power sources.

Drugstores: What they lose from brand-name pricing pressure they would make up on a movement to generics.

Generic drug makers: Generics would help the government save money under a universal healthcare system.

Low-end retailers: Obama's tax cuts would benefit primarily those with very low incomes.

Source: Citi Investment Research


 
 
Business